Secreted Metabolome of ALS-Related hSOD1(G93A) Primary Cultures of Myocytes and Implications for Myogenesis
Cells · 2023
DOI: 10.3390/cells12232751 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Roberto Stella und 6 weiteren Autor:innen. Beteiligte Einrichtung: Istituto Zooprofilattico Sperimentale delle Venezie, 35020 Legnaro, Italy. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Motor Neuron Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Padova, The Cariplo Foundation.
Abstract (Originalsprache)
Amyotrophic lateral sclerosis (ALS) is a motor neuron (MN) disease associated with progressive muscle atrophy, paralysis, and eventually death. Growing evidence demonstrates that the pathological process leading to ALS is the result of multiple altered mechanisms occurring not only in MNs but also in other cell types inside and outside the central nervous system. In this context, the involvement of skeletal muscle has been the subject of a few studies on patients and ALS animal models. In this work, by using primary myocytes derived from the ALS transgenic hSOD1(G93A) mouse model, we observed that the myogenic capability of such cells was defective compared to cells derived from control mice expressing the nonpathogenic hSOD1(WT) isoform. The correct in vitro myogenesis of hSOD1(G93A) primary skeletal muscle cells was rescued by the addition of a conditioned medium from healthy hSOD1(WT) myocytes, suggesting the existence of an in trans activity of secreted factors. To define a dataset of molecules participating in such safeguard action, we conducted comparative metabolomic profiling of a culture medium collected from hSOD1(G93A) and hSOD1(WT) primary myocytes and report here an altered secretion of amino acids and lipid-based signaling molecules. These findings support the urgency of better understanding the role of the skeletal muscle secretome in the regulation of the myogenic program and mechanisms of ALS pathogenesis and progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Istituto Zooprofilattico Sperimentale delle Venezie, 35020 Legnaro, Italy.
- Department of Biology, University of Padova, 35131 Padova, Italy.
- CIR-Myo Myology Center, University of Padova, 35131 Padova, Italy.
- Department of Biomedical Sciences, University of Padova, 35131 Padova, Italy.
- Neuroscience Institute, Consiglio Nazionale delle Ricerche, 35131 Padova, Italy.
- Padova Neuroscience Center, University of Padova, 35131 Padova, Italy.
ORCID-Profile: Roberto Stella, Raphael Severino Bonadio, Stefano Cagnin, Maria Lina Massimino, Alessandro Bertoli, Caterina Peggion
Förderung
- University of Padova
- The Cariplo Foundation
Zitieren
APA
Stella, R., Bonadio, R. S., Cagnin, S., Andreotti, R., Massimino, M. L., Bertoli, A., & Peggion, C. (2023). Secreted Metabolome of ALS-Related hSOD1(G93A) Primary Cultures of Myocytes and Implications for Myogenesis. Cells. https://doi.org/10.3390/cells12232751
Vancouver
Stella R, Bonadio RS, Cagnin S, Andreotti R, Massimino ML, Bertoli A, et al. Secreted Metabolome of ALS-Related hSOD1(G93A) Primary Cultures of Myocytes and Implications for Myogenesis. Cells. 2023. doi:10.3390/cells12232751
BibTeX
@article{Stella2023,
author = {Stella, Roberto and Bonadio, Raphael Severino and Cagnin, Stefano and Andreotti, Roberta and Massimino, Maria Lina and Bertoli, Alessandro and Peggion, Caterina},
title = {Secreted Metabolome of ALS-Related hSOD1(G93A) Primary Cultures of Myocytes and Implications for Myogenesis},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12232751}
}
EUVIMED